In silico Identification of FDA Approved Drug Candidates Targeting the RNA-binding Region of Andes Hantavirus Nucleocapsid Protein
B1 Crossref Works API · 2026-09-30 · ANDV
The Andes virus is a rodent-born RNA microorganism that can cause a serious hantavirus pulmonary syndrome (HPS) with a mortality rate approaching 50%. The recent outbreaks of the Andes virus, specifically in south America, represent an emerging public health challenge due to the risk of human-to-human transmission and the lack of approved therapeutics or vaccines. Therefore, the objective of this in silico screening is to recognize FDA drugs candidates that can target the RNA binding site of the Andes virus nucleocapsid protein (NP). Such drug candidates may possess the potential to adversely
Read at source (Crossref Works API) →
HORIZON metadata
| Source | Crossref Works API (crossref) |
|---|---|
| NATO rating | B1 — see methodology |
| Serotype | ANDV |
| Reported date | 2026-09-30 |
| Ingested at | 2026-10-06 12:50 UTC |